SCHEMBL23484283

SCHEMBL23484283

CCOC(=O)c1ccc(O)c(C(F)(F)F)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.66
CA1 P00915 5/20 0.66
CA2 P00918 5/20 0.66
CA7 P43166 5/20 0.66
CA9 Q16790 5/20 0.66
CA14 Q9ULX7 5/20 0.66
HSD17B2 P37059 1/20 0.59
ESR1 P03372 2/20 0.53
ESR2 Q92731 1/20 0.53
P4HB P07237 1/20 0.49
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
HSD17B10 Q99714 1/20 0.48
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAOA P21397 1/20 0.47
POLB P06746 1/20 0.46
PDK1 Q15118 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25048670 0.88 CA12 (0.66) CA12CA1CA2CA7CA9
SCHEMBL1993657 0.87 CA12 (0.56) CA12CA1CA2CA7CA9
SCHEMBL374633 0.86 CA12 (0.54) CA12CA1CA2CA7CA9
SCHEMBL5364276 0.86 CA12 (0.68) CA12CA1CA2CA7CA9
SCHEMBL989378 0.84 NOTUM (0.55) CA12CA1CA2CA7CA9
SCHEMBL2543756 0.84 CA12 (0.53) CA12CA1CA2CA7CA9
SCHEMBL10973660 0.83 CA12 (0.51) CA12CA1CA2CA7CA9
SCHEMBL403261 0.83 CA12 (0.51) CA12CA1CA2CA7CA9
SCHEMBL3311471 0.83 LMNA (0.54) CA12CA1CA2CA7CA9
SCHEMBL27871579 0.83 CA12 (0.54) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570632-B2 Indole derivatives and uses thereof for treating a cancer UNIVERSITE CLAUDE BERNARD LYON 1 (FR) 2026-03-10 US disclosed
EP-4175718-B1 INDOLE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER UNIV CLAUDE BERNARD LYON (FR) 2024-10-02 EP disclosed
US-20230278983-A1 INDOLE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER UNIVERSITE CLAUDE BERNARD LYON 1 (FR) 2023-09-07 US disclosed
EP-4175718-A1 INDOLE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER UNIVERSITE CLAUDE BERNARD - LYON 1 (FR) 2023-05-10 EP disclosed
CN-115843271-A Indole derivatives and their use for the treatment of cancer 克洛德贝纳尔-里昂第一大学 2023-03-24 CN disclosed
WO-2022008475-A1 INDOLE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER UNIVERSITE CLAUDE BERNARD LYON 1 (FR) 2022-01-13 WO disclosed
US-20210171883-A1 ANTIVIRAL WIPER FUJIFILM CORPORATION (JP) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570632-B2 Indole derivatives and uses thereof for treating a cancer CKS2, CSNK2A3, CSNK1A1L CA12 414/4885CA1 476/4885CA2 274/4885
US-20230278983-A1 INDOLE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER CSNK2A1, IDO1, CSNK2A3 CA12 666/4885CA1 689/4885CA2 342/4885
US-20210171883-A1 ANTIVIRAL WIPER CGAS, PRKX, PDE4C CA12 2396/4885CA1 2414/4885CA2 1789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.